Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENZON PHARMACEUTICALS, INC.

(ENZN)
  Report
 SummaryQuotesChartsNewsCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Otc Markets
11/29/2021 11/30/2021 12/01/2021 12/02/2021 12/03/2021 Date
0.378(c) 0.3695(c) 0.3608(c) 0.395(c) 0.39(c) Last
26 800 8 000 17 661 127 445 200 870 Volume
-3.08% -2.25% -2.35% +9.48% -1.27% Change
More quotes
Estimated financial data (e) (USD)
Sales 2019 0,21 M - -
Net income 2019 -0,98 M - -
Net cash position 2019 5,45 M - -
P/E ratio 2019 -9,30x
Yield 2019 -
Sales 2020 0,05 M - -
Net income 2020 -1,31 M - -
Net cash position 2020 48,1 M - -
P/E ratio 2020 -7,17x
Yield 2020 -
Capitalization 28,9 M 28,9 M -
EV / Sales 2019 17,7x
EV / Sales 2020 -571x
Nbr of Employees 1
Free-Float 89,2%
More Financials
Company
Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies. 
More about the company
All news about ENZON PHARMACEUTICALS, INC.
11/05ENZON PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
11/05Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Mon..
CI
08/05ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
08/05Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended June ..
CI
06/08ENZON PHARMACEUTICALS : CONTINENTAL STOCK TRANSFER & TRUST COMPANY (Form 8-K)
PU
06/08ENZON PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Material Modific..
AQ
05/04ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
05/04Enzon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March ..
CI
02/23ENZON PHARMACEUTICALS : Management's Discussion and Analysis of Financial Condition and Re..
AQ
02/23Enzon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 3..
CI
01/05ENZON PHARMACEUTICALS : CEO Andrew Rackear to Retire, Richard L. Feinstein, Enzon's CFO, t..
AQ
01/04ENZON PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Stateme..
AQ
01/04Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire;áRichard L. Feinstein, Enzon's..
GL
01/04Enzon Pharmaceuticals, Inc. Appoints Richard L. Feinstein as Secretary
CI
01/04Enzon Pharmaceuticals, Inc. Announces Executive Changes
CI
More news
News in other languages on ENZON PHARMACEUTICALS, INC.

- No features available -

More news
Chart ENZON PHARMACEUTICALS, INC.
Duration : Period :
Enzon Pharmaceuticals, Inc. Technical Analysis Chart | ENZN | US2939041081 | MarketScreener
Income Statement Evolution
Managers and Directors
Richard L. Feinstein Secretary, Chief Executive & Financial Officer
Randolph C. Read Chairman
Jennifer Isacoff McNealey Independent Director
Jordan Bleznick Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ENZON PHARMACEUTICALS, INC.59.02%29
GILEAD SCIENCES, INC.19.40%87 255
BIONTECH SE310.30%83 098
REGENERON PHARMACEUTICALS31.23%66 409
WUXI APPTEC CO., LTD.26.31%65 758
VERTEX PHARMACEUTICALS-13.76%51 819